Thematics Asset Management Has $6.91 Million Holdings in Zoetis Inc. (NYSE:ZTS)

Thematics Asset Management increased its stake in shares of Zoetis Inc. (NYSE:ZTS) by 4.6% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 35,354 shares of the company’s stock after acquiring an additional 1,557 shares during the period. Thematics Asset Management’s holdings in Zoetis were worth $6,907,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Cetera Investment Advisers lifted its stake in Zoetis by 275.2% in the 1st quarter. Cetera Investment Advisers now owns 96,085 shares of the company’s stock valued at $16,259,000 after acquiring an additional 70,476 shares in the last quarter. Simplify Asset Management Inc. bought a new position in Zoetis in the third quarter valued at $11,684,000. Soltis Investment Advisors LLC acquired a new stake in Zoetis in the 1st quarter valued at $688,000. Bank Pictet & Cie Asia Ltd. lifted its position in Zoetis by 41.0% during the 2nd quarter. Bank Pictet & Cie Asia Ltd. now owns 37,500 shares of the company’s stock worth $6,501,000 after buying an additional 10,900 shares in the last quarter. Finally, Swedbank AB boosted its stake in shares of Zoetis by 56.2% during the 2nd quarter. Swedbank AB now owns 1,946,277 shares of the company’s stock worth $337,407,000 after buying an additional 700,398 shares during the last quarter. 92.80% of the stock is owned by institutional investors.

Analysts Set New Price Targets

ZTS has been the topic of a number of recent research reports. Argus raised Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. JPMorgan Chase & Co. increased their price objective on Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Piper Sandler boosted their target price on shares of Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, August 14th. Stifel Nicolaus increased their price target on shares of Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research note on Wednesday, September 18th. Finally, BTIG Research boosted their price objective on shares of Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, August 12th. Ten analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Zoetis has an average rating of “Buy” and an average target price of $221.44.

Zoetis Stock Performance

Shares of ZTS stock traded down $3.02 during midday trading on Tuesday, hitting $175.69. 204,788 shares of the company were exchanged, compared to its average volume of 2,540,794. The firm has a market capitalization of $79.27 billion, a P/E ratio of 33.59, a PEG ratio of 2.71 and a beta of 0.90. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.27 and a current ratio of 3.69. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $201.92. The firm’s 50 day moving average price is $185.31 and its two-hundred day moving average price is $180.79.

Zoetis (NYSE:ZTS) last posted its earnings results on Monday, November 4th. The company reported $1.58 EPS for the quarter, beating the consensus estimate of $1.46 by $0.12. The company had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.29 billion. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The firm’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.36 earnings per share. As a group, equities research analysts anticipate that Zoetis Inc. will post 5.9 earnings per share for the current year.

Zoetis Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 3rd. Stockholders of record on Thursday, October 31st will be given a $0.432 dividend. The ex-dividend date is Thursday, October 31st. This represents a $1.73 dividend on an annualized basis and a dividend yield of 0.98%. Zoetis’s payout ratio is presently 32.52%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.